Cigarette Smoking and Plasma High‐density Lipoprotein Cholesterol: The Lipid Research Clinics Program Prevalence Study

The relationship between cigarette smoking and high-density lipoprotein (HDL) cholesterol was examined in 2663 men and 2553 women ages 20-69 years in 10 North American populations. Men and women who were smokers had significantly (p < 0.01) lower HDL cholesterol levels than nonsmokers, and heavier smokers had lower HDL cholesterol levels than lighter smokers. Using multiple linear regression analysis to adjust for differences in age, obesity, alcohol consumption and regular exercise increased the differences in HDL cholesterol levels between smokers and nonsmokers. For men who smoked 20 or more cigarettes/day, adjusted values averaged 5.3 mg/dl (11%) lower than those for nonsmokers (p < 0.01). Women who used gonadal hormones were analyzed separately from those who did not. In both groups, women who smoked 20 or more cigarettes/day had lower HDL cholesterol levels than nonsmokers: 9.4 mg/dl (14%) lower in hormone users and 8.6 mg/dl (14%) lower in nonusers (both p < 0.01). These findings indicate that cigarette smoking is associated with substantially lower levels of HDL cholesterol. Further, this association appears to be dose-dependent and is consistent with other research, indicating a possible causal relationship between cigarette smoking and lower HDL cholesterol.

[1]  W. Haskell,et al.  Strenuous Physical Activity, Treadmill Exercise Test Performance and Plasma High‐density Lipoprotein Cholesterol: The Lipid Research Clinics Program Prevalence Study , 1980, Circulation.

[2]  O. Williams,et al.  The association of plasma high-density lipoprotein cholesterol with dietary intake and alcohol consumption. The Lipid Research Clinics Prevalence Study. , 1980, Circulation.

[3]  D. Jacobs,et al.  Plasma High‐density Lipoprotein Cholesterol: Association with Measurements of Body Mass The Lipid Research Clinics Program Prevalence Study , 1980, Circulation.

[4]  O. Williams,et al.  Common Methods, Different Populations: The Lipid Research Clinics Program Prevalence Study , 1980, Circulation.

[5]  O. Williams,et al.  Quality Control of Plasma High‐density Lipoprotein Cholesterol Measurement Methods: The Lipid Research Clinics Program Prevalence Study , 1980, Circulation.

[6]  D. Jacobs,et al.  Lipoprotein‐Cholesterol Distributions in Selected North American Populations: The Lipid Research Clinics Program Prevalence Study , 1980, Circulation.

[7]  E. Barrett-Connor,et al.  ALTERED PLASMA LIPID AND LIPOPROTEIN LEVELS ASSOCIATED WITH ORAL CONTRACEPTIVE AND ŒSTROGEN USE Report from the Medications Working Group of the Lipid Research Clinics Program , 1979, The Lancet.

[8]  E. C. Hammond,et al.  Changes in bronchial epithelium in relation to cigarette smoking, 1955-1960 vs. 1970-1977. , 1979, The New England journal of medicine.

[9]  L. Dales,et al.  Mortality in middle-aged smokers and nonsmokers. , 1979, The New England journal of medicine.

[10]  P. Williams,et al.  HIGH-DENSITY LIPOPROTEIN AND CORONARY RISK FACTORS IN NORMAL MEN , 1979, The Lancet.

[11]  R. Krauss,et al.  Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. , 1978, The New England journal of medicine.

[12]  W. Kannel,et al.  Cigarette smoking and HDL cholesterol: the Framingham offspring study. , 1978, Atherosclerosis.

[13]  D. Thelle,et al.  Family study of high density lipoprotein cholesterol and the relation to age and sex. The Tromso Heart Study. , 2009, Acta medica Scandinavica.

[14]  D. Topping,et al.  PERIPHERAL VASCULAR DISEASE IN CIGARETTE SMOKERS AND IMPAIRED HEPATIC METABOLISM OF LIPOPROTEIN REMNANTS , 1977, The Lancet.

[15]  N. Morton,et al.  Behavioral, social, and physiological determinants of lipoprotein concentrations. , 1977, Social biology.

[16]  S. Hulley,et al.  Plasma high-density lipoprotein cholesterol level. Influence of risk factor intervention. , 1977, JAMA.

[17]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.

[18]  D. Topping Metabolic effects of carbon monoxide in relation to atherogenesis. , 1977, Atherosclerosis.

[19]  J. Medalie,et al.  Characteristics of smokers, non-smokers and ex-smokers among 10,000 adult males inIsrael. II. Physiologic, biochemical and genetic characteristics. , 1977, American journal of epidemiology.

[20]  W. Haskell,et al.  The distribution of plasma lipoproteins in middle-aged male runners. , 1976, Metabolism: clinical and experimental.

[21]  J. Medalie,et al.  Characteristics of smokers, nonsmokers and ex-smokers among 10,000 adult males in Israel. I. Distribution of selected sociodemographic and behavioral variables and the prevalence of disease. , 1975, Israel journal of medical sciences.

[22]  R. Turner,et al.  Smoking and the heart. The basis for action. , 1974, Lancet.

[23]  J. Loewen,et al.  The health consequences of smoking. , 1970, The Journal of the Arkansas Medical Society.